Joe Flanagan
Corporate Officer/Principal chez ACCUSTEM SCIENCES, INC.
Fortune : - $ au 30/04/2024
Profil
Joe Flanagan is currently the Chief Business Officer at AccuStem Sciences, Inc. He previously worked as a Principal at Amgen, Inc. and Johnson & Johnson.
He also held positions as a Manager-Regional Accounts at Novartis Oncology, Inc., Vice President-Market Development at Biodesix, Inc., Vice President-Sales at Helomics Corp.
and Predictive Oncology, Inc., and Vice President-Market Development at Agendia, Inc. Additionally, he served as an Area Vice President-Sales at Biodesix, Inc. from 2015 to 2018, Vice President-Market Development at Agendia NV from 2018 to 2019, and Vice President-Sales at CirculoGene Theranostics, Inc. from 2018 to 2019.
Mr. Flanagan completed his undergraduate degree at Florida State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ACCUSTEM SCIENCES INC
-.--% | 31/12/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Joe Flanagan
| Sociétés | Poste | Début |
|---|---|---|
| ACCUSTEM SCIENCES, INC. | Corporate Officer/Principal | 04/03/2022 |
Anciens postes connus de Joe Flanagan
| Sociétés | Poste | Fin |
|---|---|---|
CirculoGene Theranostics, Inc.
 CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Sales & Marketing | 01/07/2019 |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Sales & Marketing | 01/05/2019 |
| BIODESIX, INC. | Sales & Marketing | 01/07/2018 |
| PREDICTIVE ONCOLOGY INC. | Sales & Marketing | - |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Corporate Officer/Principal | - |
Formation de Joe Flanagan
| Florida State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| BIODESIX, INC. | Health Services |
| PREDICTIVE ONCOLOGY INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Helomics Corp.
 Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | Health Services |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
| AccuStem Sciences, Inc. | |
Agendia NV
Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Health Services |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | Health Technology |